25 Years of Impact

 

Advancing Patient Health And Safety

 

For 25 years, ProPharma has partnered with organizations around the world to navigate complexity, accelerate progress, and help bring safer therapies to patients.

 

 


Celebrating 25 Years of Impact.
One Story at a Time.

Since 2001, ProPharma has grown alongside the clients, colleagues, and communities we serve. Behind every milestone are people whose expertise, dedication, and collaboration helped move important work forward. 25 Years, 25 Stories celebrates those individuals, and the moments that have shaped who we are today.

ProPharma 25 Years of Impact

25 Years. 25 Stories. One Shared Purpose.

Meet the people behind our progress and discover the experiences, breakthroughs, and defining moments that have shaped ProPharma over the past 25 years.

 

 

"Over the years, I've learned that success isn't measured solely by the number of programs completed or milestones achieved. It's measured by the opportunity to help advance therapies that can make a meaningful difference in people's lives."

 

 

 

 

 


Matthew Weinberg

President, Regulatory Sciences

"Although I've spent much of my career in the life sciences industry, my perspective changed dramatically after experiencing an unexpected health journey...That experience gave me a completely different appreciation for our industry."

 





Andrea Oldham

Vice President, Quality & Compliance

"I had the opportunity to be involved in an N-of-1 project and meet with the mother of a patient whose story brought our mission to life in a very personal way. Connecting with her not only as a marketing professional, but as a mom, was a powerful reminder that behind every project, submission, and milestone is a person hoping for a better outcome."

 

Kristen Young

Director, Marketing

Our Impact Continues

Explore more stories from the people who have shaped ProPharma over the past 25 years. Visit LinkedIn to discover the experiences, milestones, and moments of impact that continue to define our future. 

Explore More Stories

News & Insights

Thought Leadership Webinars Press Awards Resource Library
QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Regulation

July 23, 2026

QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Re...

The FDA's transition to the QMSR simplifies compliance, emphasizing risk management and aligning with global standards for medical devices compared to QMR.

Read Full Article
Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

July 20, 2026

Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

Discover effective strategies for building relationships with clinical trial sites to streamline the study start-up process and enhance activation timelines.

Read Full Article
FDA Weighs in on Popular Peptides

July 17, 2026

FDA Weighs in on Popular Peptides

FDA is reviewing seven popular peptides for potential inclusion on the 503A Bulks List. Learn what the review means for compounding pharmacies and patient access.

Read Full Article
View all Thought Leadership
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

Read Full Article
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

Read Full Article
ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

Read Full Article
View all Press
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Read Full Article
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

Read Full Article
ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Read Full Article
View all Awards
Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Read Full Article
Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Read Full Article
Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Read Full Article
View all Resources
Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Watch the Replay
Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Watch the Replay
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

Watch the Replay
View all Webinars

News & Insights

QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Regulation

July 23, 2026

QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Re...

The FDA's transition to the QMSR simplifies compliance, emphasizing risk management and aligning with global standards for medical devices compared to QMR.

Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

July 20, 2026

Building Relationships with Sites: The Hidden Driver of Faster Start-Ups

Discover effective strategies for building relationships with clinical trial sites to streamline the study start-up process and enhance activation timelines.

FDA Weighs in on Popular Peptides

July 17, 2026

FDA Weighs in on Popular Peptides

FDA is reviewing seven popular peptides for potential inclusion on the 503A Bulks List. Learn what the review means for compounding pharmacies and patient access.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Case Study Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A Regulatory and Pharmacovigilance-Led Solution - ProPharma

July 15, 2026

Ensuring Continuity of Neonatal Vitamin Prophylaxis During a Product Shortage: A...

Product shortages involving essential medicines can create significant clinical and regulatory challenges, particularly when vulnerable patient populations depend on uninterrupted access to...

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

June 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Previous Resource Arrow Next Resource Arrow
Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

June 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

Previous Webinar Arrow Next Webinar Arrow